179 related articles for article (PubMed ID: 38398385)
1. The Status of Fertility Preservation (FP) Insurance Mandates and Their Impact on Utilization and Access to Care.
Sauerbrun-Cutler MT; Rollo A; Gadson A; Eaton JL
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398385
[TBL] [Abstract][Full Text] [Related]
2. Fertility preservation before and after cancer treatment in children, adolescents, and young adults.
Yang EH; Strohl HB; Su HI
Cancer; 2024 Feb; 130(3):344-355. PubMed ID: 37962199
[TBL] [Abstract][Full Text] [Related]
3. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
4. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F;
Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
[TBL] [Abstract][Full Text] [Related]
5. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
[TBL] [Abstract][Full Text] [Related]
6. Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
Saito S; Yamada M; Yano R; Takahashi K; Ebara A; Sakanaka H; Matsumoto M; Ishimaru T; Utsuno H; Matsuzawa Y; Ooka R; Fukuoka M; Akashi K; Kamijo S; Hamatani T; Tanaka M
J Ovarian Res; 2023 Aug; 16(1):159. PubMed ID: 37563616
[TBL] [Abstract][Full Text] [Related]
7. Survey of young women with breast cancer to identify rates of fertility preservation (FP) discussion and barriers to FP care.
Sauerbrun-Cutler MT; Pandya S; Recabo O; Raker C; Clark MA; Robison K
J Assist Reprod Genet; 2023 Aug; 40(8):2003-2011. PubMed ID: 37329421
[TBL] [Abstract][Full Text] [Related]
8. A Geospatial Analysis of Disparities in Access to Oncofertility Services.
Peipert BJ; Potapragada NR; Lantos PM; Harris BS; Reinecke J; Goldman KN
JAMA Oncol; 2023 Oct; 9(10):1364-1370. PubMed ID: 37561485
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Health Insurance Benefit Mandates for Fertility Preservation Among 11 US States.
Flores Ortega RE; Yoeun SW; Mesina O; Kaiser BN; McMenamin SB; Su HI
JAMA Health Forum; 2021 Dec; 2(12):e214309. PubMed ID: 36218913
[TBL] [Abstract][Full Text] [Related]
10. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
11. ESHRE guideline: female fertility preservation.
; Anderson RA; Amant F; Braat D; D'Angelo A; Chuva de Sousa Lopes SM; Demeestere I; Dwek S; Frith L; Lambertini M; Maslin C; Moura-Ramos M; Nogueira D; Rodriguez-Wallberg K; Vermeulen N
Hum Reprod Open; 2020; 2020(4):hoaa052. PubMed ID: 33225079
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of boys who have undergone a testicular biopsy for fertility preservation.
Kanbar M; de Michele F; Giudice MG; Desmet L; Poels J; Wyns C
Hum Reprod; 2021 Jan; 36(1):26-39. PubMed ID: 33259629
[TBL] [Abstract][Full Text] [Related]
13. A comparison of fertility preservation outcomes in patients who froze oocytes, embryos, or ovarian tissue for medically indicated circumstances: a systematic review and meta-analysis.
Ní Dhonnabháin B; Elfaki N; Fraser K; Petrie A; Jones BP; Saso S; Hardiman PJ; Getreu N
Fertil Steril; 2022 Jun; 117(6):1266-1276. PubMed ID: 35459522
[TBL] [Abstract][Full Text] [Related]
14. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation.
Fraison E; Huberlant S; Labrune E; Cavalieri M; Montagut M; Brugnon F; Courbiere B
Hum Reprod; 2023 Mar; 38(3):489-502. PubMed ID: 36421038
[TBL] [Abstract][Full Text] [Related]
15. Cryobiology in human assisted reproductive technology. Would Hippocrates approve?
Bredkjaer HE; Grudzinskas JG
Early Pregnancy (Cherry Hill); 2001 Jul; 5(3):211-3. PubMed ID: 11753534
[TBL] [Abstract][Full Text] [Related]
16. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
17. Fertility preservation for cancer patients: treatment gaps and considerations in patients' choices.
Kappy M; Lieman HJ; Pollack S; Buyuk E
Arch Gynecol Obstet; 2021 Jun; 303(6):1617-1623. PubMed ID: 33544203
[TBL] [Abstract][Full Text] [Related]
18. The Experience of Fertility Preservation in a Single Tertiary Center in Korea.
Choi YJ; Hong YH; Kim S; Kim SK; Lee JR; Suh CS
Front Endocrinol (Lausanne); 2022; 13():845051. PubMed ID: 35518927
[TBL] [Abstract][Full Text] [Related]
19. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
20. Fertility preservation in breast cancer with case-based examples for guidance.
Hampe ME; Rhoton-Vlasak AS
J Assist Reprod Genet; 2020 Mar; 37(3):717-729. PubMed ID: 32008180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
